Skip to main content
. 2017 May 19;8(26):43237–43247. doi: 10.18632/oncotarget.18018

Figure 2. The in vitro effects of differential ABCG2 expression on DMC inhibition of GSCs.

Figure 2

(A) The cell growth inhibitory effects of 10μM or 30μM DMC on GSCs as measured by MTT assay. (B) Western blot analysis of ABCG2 expression in GSCs transfected with ABCG2 shRNA lentiviral vector. (C) The cell growth inhibition rate of 10μM or 30μM DMC on ABCG2 knockdown GSCs (ABCG2 shRNA) as determined by MTT assay. (D) Western blot analysis of ABCG2 expression in GSCs transfected with ABCG2 overexpression lentiviral vector. (E) The cell growth inhibition rate of 10μM or 30μM DMC on ABCG2 overexpressed GSCs as determined by MTT assay. “Lenti-GFP-ABCG2” is denoted as “ABCG vector”.“Lenti-GFP-ABCG2 shRNA” is denoted as “ABCG2 shRNA”.